Knowledge and Attitudes Concerning Aducanumab Among Older Americans After FDA Approval for Treatment of Alzheimer Disease
Julie Zissimopoulos, Mireille Jacobson, Yi Chen, Soo Borson
Abstract
This survey study examines the understanding of aducanumab and attitudes toward its potential outcomes among older Americans after the drug's approval by the US Food and Drug Administration (FDA) for the treatment for Alzheimer disease.
Topics & Concepts
Food and drug administrationDiseaseMedicineGerontologyAlzheimer's diseaseDrugFamily medicinePsychologyPsychiatryEnvironmental healthPathologyBioeconomy and Sustainability DevelopmentCholinesterase and Neurodegenerative DiseasesPharmaceutical Economics and Policy